Literature DB >> 33847934

Complement C3 Deposition on Endothelial Cells Revealed by Flow Cytometry.

Idris Boudhabhay1, Anne Grunenwald1, Lubka T Roumenina2.   

Abstract

The three pathways of the complement system converge toward the cleavage of the central complement component C3 into its activated fragments, with C3b being able to bind covalently to the activating surface. The endothelial cells are among the major targets for complement attack in pathological conditions, as the atypical hemolytic uremic syndrome. Therefore, study of complement C3 deposition on endothelial cells by flow cytometry is a sensitive test to measure complement activation. This test can be used as a research or clinical tool to test complement activation induced by patients' sera or to test the functional consequences of newly discovered complement mutations as well as different triggers of endothelial cells injury.

Entities:  

Keywords:  C3; Cell imaging; Complement system; Endothelial cells; Flow cytometry

Year:  2021        PMID: 33847934     DOI: 10.1007/978-1-0716-1016-9_9

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  16 in total

1.  A Familial C3GN Secondary to Defective C3 Regulation by Complement Receptor 1 and Complement Factor H.

Authors:  Sophie Chauvet; Lubka T Roumenina; Sarah Bruneau; Maria Chiara Marinozzi; Tania Rybkine; Elizabeth C Schramm; Anuja Java; John P Atkinson; Jean Claude Aldigier; Frank Bridoux; Guy Touchard; Veronique Fremeaux-Bacchi
Journal:  J Am Soc Nephrol       Date:  2015-10-15       Impact factor: 10.121

2.  P-selectin drives complement attack on endothelium during intravascular hemolysis in TLR-4/heme-dependent manner.

Authors:  Nicolas S Merle; Romain Paule; Juliette Leon; Marie Daugan; Tania Robe-Rybkine; Victoria Poillerat; Carine Torset; Véronique Frémeaux-Bacchi; Jordan D Dimitrov; Lubka T Roumenina
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-08       Impact factor: 11.205

3.  Complement activation in sickle cell disease: Dependence on cell density, hemolysis and modulation by hydroxyurea therapy.

Authors:  Lubka T Roumenina; Philippe Chadebech; Gwellaouen Bodivit; Paula Vieira-Martins; Anne Grunenwald; Idris Boudhabhay; Victoria Poillerat; Sadaf Pakdaman; Laurent Kiger; Alicia Jouard; Etienne Audureau; France Pirenne; Frédéric Galactéros; Véronique Frémeaux-Bacchi; Pablo Bartolucci
Journal:  Am J Hematol       Date:  2020-02-19       Impact factor: 10.047

4.  Complement activation by heme as a secondary hit for atypical hemolytic uremic syndrome.

Authors:  Marie Frimat; Fanny Tabarin; Jordan D Dimitrov; Caroline Poitou; Lise Halbwachs-Mecarelli; Veronique Fremeaux-Bacchi; Lubka T Roumenina
Journal:  Blood       Date:  2013-05-21       Impact factor: 22.113

Review 5.  Spectrum of complement-mediated thrombotic microangiopathies: pathogenetic insights identifying novel treatment approaches.

Authors:  Magdalena Riedl; Fadi Fakhouri; Moglie Le Quintrec; Damien G Noone; Therese C Jungraithmayr; Veronique Fremeaux-Bacchi; Christoph Licht
Journal:  Semin Thromb Hemost       Date:  2014-06-09       Impact factor: 4.180

6.  Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome.

Authors:  Lubka T Roumenina; Mathieu Jablonski; Christophe Hue; Jacques Blouin; Jordan D Dimitrov; Marie-Agnes Dragon-Durey; Mathieu Cayla; Wolf H Fridman; Marie-Alice Macher; David Ribes; Luc Moulonguet; Lionel Rostaing; Simon C Satchell; Peter W Mathieson; Catherine Sautes-Fridman; Chantal Loirat; Catherine H Regnier; Lise Halbwachs-Mecarelli; Veronique Fremeaux-Bacchi
Journal:  Blood       Date:  2009-07-07       Impact factor: 22.113

Review 7.  Complement System Part I - Molecular Mechanisms of Activation and Regulation.

Authors:  Nicolas S Merle; Sarah Elizabeth Church; Veronique Fremeaux-Bacchi; Lubka T Roumenina
Journal:  Front Immunol       Date:  2015-06-02       Impact factor: 7.561

8.  Heme Drives Susceptibility of Glomerular Endothelium to Complement Overactivation Due to Inefficient Upregulation of Heme Oxygenase-1.

Authors:  Olivia May; Nicolas S Merle; Anne Grunenwald; Viviane Gnemmi; Juliette Leon; Cloé Payet; Tania Robe-Rybkine; Romain Paule; Florian Delguste; Simon C Satchell; Peter W Mathieson; Marc Hazzan; Eric Boulanger; Jordan D Dimitrov; Veronique Fremeaux-Bacchi; Marie Frimat; Lubka T Roumenina
Journal:  Front Immunol       Date:  2018-12-20       Impact factor: 7.561

9.  Complement factor B mutations in atypical hemolytic uremic syndrome-disease-relevant or benign?

Authors:  Maria Chiara Marinozzi; Laura Vergoz; Tania Rybkine; Stephanie Ngo; Serena Bettoni; Anastas Pashov; Mathieu Cayla; Fanny Tabarin; Mathieu Jablonski; Christophe Hue; Richard J Smith; Marina Noris; Lise Halbwachs-Mecarelli; Roberta Donadelli; Veronique Fremeaux-Bacchi; Lubka T Roumenina
Journal:  J Am Soc Nephrol       Date:  2014-03-20       Impact factor: 10.121

10.  A prevalent C3 mutation in aHUS patients causes a direct C3 convertase gain of function.

Authors:  Lubka T Roumenina; Marie Frimat; Elizabeth C Miller; Francois Provot; Marie-Agnes Dragon-Durey; Pauline Bordereau; Sylvain Bigot; Christophe Hue; Simon C Satchell; Peter W Mathieson; Christiane Mousson; Christian Noel; Catherine Sautes-Fridman; Lise Halbwachs-Mecarelli; John P Atkinson; Arnaud Lionet; Veronique Fremeaux-Bacchi
Journal:  Blood       Date:  2012-01-13       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.